{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:36:20Z","timestamp":1793756180583,"version":"4.6.1"},"reference-count":60,"publisher":"Informa UK Limited","issue":"18","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2023,12,12]]},"DOI":"10.1080\/14656566.2023.2269854","type":"journal-article","created":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T05:29:37Z","timestamp":1697002177000},"page":"2187-2198","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":11,"title":["Bexagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, for improvement of glycemia in type 2 diabetes mellitus: a systematic review and meta-analysis"],"prefix":"10.1080","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0654-5998","authenticated-orcid":false,"given":"Sagar","family":"Dholariya","sequence":"first","affiliation":[{"name":"All India Institute of Medical Sciences","place":["Rajkot, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6525-5950","authenticated-orcid":false,"given":"Siddhartha","family":"Dutta","sequence":"additional","affiliation":[{"name":"All India Institute of Medical Sciences","place":["Rajkot, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2397-9023","authenticated-orcid":false,"given":"Ragini","family":"Singh","sequence":"additional","affiliation":[{"name":"All India Institute of Medical Sciences","place":["Rajkot, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5024-970X","authenticated-orcid":false,"given":"Deepak","family":"Parchwani","sequence":"additional","affiliation":[{"name":"All India Institute of Medical Sciences","place":["Rajkot, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7968-2312","authenticated-orcid":false,"given":"Amit","family":"Sonagra","sequence":"additional","affiliation":[{"name":"All India Institute of Medical Sciences","place":["Rajkot, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0081-5296","authenticated-orcid":false,"given":"Mehul","family":"Kaliya","sequence":"additional","affiliation":[{"name":"All India Institute of Medical Sciences","place":["Rajkot, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,10,20]]},"reference":[{"key":"e_1_3_5_3_1","volume-title":"IDF diabetes atlas 10th edition scientific committee. IDF DIABETES ATLAS [internet]","author":"Magliano DJ","year":"2021","unstructured":"Magliano DJ, Boyko EJ. IDF diabetes atlas 10th edition scientific committee. IDF DIABETES ATLAS [internet]. 10th ed. Brussels: International Diabetes Federation; 2021. Chapter 3, Global picture.","edition":"10"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.2991\/jegh.k.191028.001"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjnph-2020-000218"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.3390\/nu13124410"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.4082\/kjfm.20.0165"},{"key":"e_1_3_5_8_1","volume-title":"Endotext [internet]","author":"Schroeder EB.","year":"2000","unstructured":"Schroeder EB. Management of type 2 diabetes: selecting amongst Available pharmacological agents. In: Feingold K, Anawalt B, and Blackman M, editors. Endotext [internet]. South Dartmouth (MA): MDText.com, Inc; 2000. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK425702\/"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI142243"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc22-S009"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S331654"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.3803\/EnM.2022.105"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.13255"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00424-020-02361-w"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.3390\/diseases8020014"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.749010"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-04212-9"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-023-01848-x"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2011.01.001"},{"key":"e_1_3_5_20_1","unstructured":"TheracosBio LLC BRENZAVVY (bexagliflozin) tablets for oral use: US prescribing information. 2023 [cited 2023 May 19]. Available from: https:\/\/www.fda. gov\/."},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.4155\/fmc-2020-0154"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13833"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/obr.12755"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1611925"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1812389"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1515920"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2024816"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.recesp.2021.06.016"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1411"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5928"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1266"},{"key":"e_1_3_5_33_1","unstructured":"The Cochrane Collaboration. Fixed or random effects?: Cochrane training Cochrane handbook for systematic reviews of Interventions. 2022 [updated 2022; cited 2023 Jul 1]. Available from: https:\/\/training.cochrane.org\/handbook\/current\/chapter-10#section-10-10-4-1."},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.4097\/kjae.2018.71.2.103"},{"key":"e_1_3_5_35_1","unstructured":"The Cochrane Collaboration. Heterogeneity: Cochrane Training Cochrane Handbook for Systematic Reviews of Interventions. 2022 [cited 2023 Jul 2]. Available from: https:\/\/training.cochrane.org\/handbook\/current\/chapter-10#section-10-10."},{"key":"e_1_3_5_36_1","unstructured":"Review Manager (RevMan) [computer program]. Version 5.4.1 the Cochrane collaboration. 2020 [cited 2022 May 29]. Available from: https:\/\/training.cochrane.org\/online-learning\/core-software-cochrane-reviews\/revman\/revman-5-download\/download-and-installation."},{"key":"#cr-split#-e_1_3_5_37_1.1","unstructured":"Lock JP Safety and efficacy of bexagliflozin as monotherapy in patients with type 2 diabetes. ClinicalTrials.Gov identifier: NCT02715258. Posted 2016 Mar 22"},{"key":"#cr-split#-e_1_3_5_37_1.2","unstructured":"cited 2023 Mar 10]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT02715258."},{"key":"#cr-split#-e_1_3_5_38_1.1","unstructured":"Lock JP. Bexagliflozin efficacy and safety trial (BEST). ClinicalTrials. gov identifier: NCT02558296. Posted 2015 Sep 23"},{"key":"#cr-split#-e_1_3_5_38_1.2","unstructured":"cited 2023 Mar 10]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT02558296."},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13928"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2019.03.417"},{"key":"#cr-split#-e_1_3_5_41_1.1","unstructured":"Lock JP Safety and efficacy of bexagliflozin compared to placebo as add-on therapy to metformin in type 2 diabetes subjects. Clinical- Trials.Gov Identifier: NCT03259789. [Posted 2017 Aug 24"},{"key":"#cr-split#-e_1_3_5_41_1.2","unstructured":"cited 2023 Mar 10]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03259789."},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13801"},{"key":"#cr-split#-e_1_3_5_43_1.1","unstructured":"Lock JP Safety and efficacy of bexagliflozin compared to glimepiride as add-on therapy to metformin in type 2 diabetes subjects. Clinical- Trials.Gov Identifier: NCT02769481. [Posted 2016 May 11"},{"key":"#cr-split#-e_1_3_5_43_1.2","unstructured":"cited 2023 Mar 10]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT02769481."},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-022-00690-7"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-S006"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1080\/00498254.2019.1654634"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.2337\/db13-0604"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S233538"},{"key":"e_1_3_5_49_1","unstructured":"Lock JP Safety and efficacy of bexagliflozin in subjects with moderate hepatic impairment. ClinicalTrials. gov identifier: NCT03557658. [cited 2018 Jun 15]. Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT0355765."},{"key":"e_1_3_5_50_1","unstructured":"Freeman M Study to evaluate effects of probenecid rifampin and verapamil on bexagliflozin in healthy subjects. ClinicalTrials. gov identifier: NCT03296800. [cited 2017 Sep 28]. Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT03296800."},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacbts.2019.11.007"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40360-017-0125-x"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10517-021-05191-7"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2022.05.005"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20030629"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.6139"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13876"},{"key":"e_1_3_5_58_1","unstructured":"Higgins JPT Thomas J Chandler J et al. Cochrane handbook for systematic reviews of interventions version 6.3 (updated February 2022). Cochrane: Wiley; 2022. Available from: www.training.cochrane.org\/handbook."}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2023.2269854","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T04:06:09Z","timestamp":1744689969000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14656566.2023.2269854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,20]]},"references-count":60,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2023,12,12]]}},"alternative-id":["10.1080\/14656566.2023.2269854"],"URL":"https:\/\/doi.org\/10.1080\/14656566.2023.2269854","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,20]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-07-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}